RO70892A - Procede pour -a preparation de 3,4-dimethoxy-n-(3-(4-methoxyphenyle)-1-methyle-n-propyle)-phenethylamine - Google Patents

Procede pour -a preparation de 3,4-dimethoxy-n-(3-(4-methoxyphenyle)-1-methyle-n-propyle)-phenethylamine

Info

Publication number
RO70892A
RO70892A RO7383749A RO8374973A RO70892A RO 70892 A RO70892 A RO 70892A RO 7383749 A RO7383749 A RO 7383749A RO 8374973 A RO8374973 A RO 8374973A RO 70892 A RO70892 A RO 70892A
Authority
RO
Romania
Prior art keywords
penetylamine
dimethoxy
methoxyphenyl
propyl
methyl
Prior art date
Application number
RO7383749A
Other languages
English (en)
Romanian (ro)
Inventor
Ronald R Tuttle
Jack Mills
Original Assignee
Eli Lilly And Co,Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RO70892(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Co,Us filed Critical Eli Lilly And Co,Us
Publication of RO70892A publication Critical patent/RO70892A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RO7383749A 1972-04-12 1973-04-12 Procede pour -a preparation de 3,4-dimethoxy-n-(3-(4-methoxyphenyle)-1-methyle-n-propyle)-phenethylamine RO70892A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (1)

Publication Number Publication Date
RO70892A true RO70892A (fr) 1982-02-26

Family

ID=22918877

Family Applications (2)

Application Number Title Priority Date Filing Date
RO7374457A RO65105A (fr) 1972-04-12 1973-04-12 Procede pour la preparation des derives de dopamine
RO7383749A RO70892A (fr) 1972-04-12 1973-04-12 Procede pour -a preparation de 3,4-dimethoxy-n-(3-(4-methoxyphenyle)-1-methyle-n-propyle)-phenethylamine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RO7374457A RO65105A (fr) 1972-04-12 1973-04-12 Procede pour la preparation des derives de dopamine

Country Status (31)

Country Link
JP (2) JPS5825656B2 (fr)
KR (1) KR790000113B1 (fr)
AR (1) AR203822A1 (fr)
AT (1) AT323719B (fr)
AU (1) AU472734B2 (fr)
BE (1) BE798051A (fr)
BG (1) BG23001A3 (fr)
CA (1) CA1018188A (fr)
CH (2) CH569691A5 (fr)
CS (2) CS190406B2 (fr)
CY (1) CY963A (fr)
DD (1) DD107670B3 (fr)
DE (1) DE2317710C2 (fr)
DK (1) DK142750C (fr)
ES (1) ES413639A1 (fr)
FR (1) FR2182947B1 (fr)
GB (1) GB1392674A (fr)
HK (1) HK50178A (fr)
HU (2) HU167597B (fr)
IE (1) IE37511B1 (fr)
IL (1) IL42016A (fr)
KE (1) KE2870A (fr)
MY (1) MY7800381A (fr)
NL (1) NL174459C (fr)
PH (1) PH11041A (fr)
PL (2) PL90695B1 (fr)
RO (2) RO65105A (fr)
SE (1) SE399064B (fr)
SU (1) SU496719A3 (fr)
YU (2) YU36483B (fr)
ZA (1) ZA732136B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (fr) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ZA825227B (en) * 1981-07-22 1984-03-28 Syntex Inc Substituted pyrrolidine cardiovascular system regulators antihypertensives
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
JPH0383364U (fr) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
ATE155125T1 (de) * 1993-04-13 1997-07-15 Duphar Int Res Herstellung von dobutamin verbindungen
EP0620208B1 (fr) * 1993-04-13 1997-07-09 Duphar International Research B.V Production de composés de la dobutamine
WO2004031129A2 (fr) 2002-10-03 2004-04-15 New Era Biotech, Ltd. Nouveaux composes destines au traitement des maladies auto-immunes, des maladies immuno-allergiques et des rejets en cas de greffes d'organes ou de tissus
CA2560922C (fr) 2004-03-26 2014-01-07 New Era Biotech, Ltd. Ameliorations apportees a des composes destines a etre utilises dans le traitement du sida ou d'autres maladies virales et infections associees au vih et compositions contenant ces composes, methodes de traitement de ces maladies et de ces infections et methodes de fabrication de ces composes et de ces compositions
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
US9192585B2 (en) 2009-07-31 2015-11-24 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
EP2747759A4 (fr) * 2011-08-25 2015-05-13 Cognition Therapeutics Inc Compositions et méthodes pour le traitement de maladies neurodégénératives
AU2015210852B2 (en) 2014-01-31 2019-01-24 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
DK3634394T3 (da) 2017-05-15 2026-03-02 Cognition Therapeutics Inc Sammensætninger til behandling af neurogenerative sygdomme
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法
CN117326958B (zh) * 2023-09-21 2025-07-11 锦州奥鸿药业有限责任公司 一种高纯度盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
DK142750C (da) 1981-08-17
NL174459C (nl) 1984-06-18
CA1018188A (en) 1977-09-27
PH11041A (en) 1977-10-25
BE798051A (fr) 1973-10-11
AT323719B (de) 1975-07-25
JPS497237A (fr) 1974-01-22
AU5438573A (en) 1974-10-17
IE37511B1 (en) 1977-08-03
JPS58131945A (ja) 1983-08-06
YU36483B (en) 1984-02-29
KR790000113B1 (en) 1979-03-20
HU167597B (fr) 1975-11-28
HK50178A (en) 1978-09-15
RO65105A (fr) 1980-01-15
DD107670B3 (de) 1988-04-06
CS190406B2 (en) 1979-05-31
MY7800381A (en) 1978-12-31
IL42016A (en) 1976-05-31
CH580563A5 (fr) 1976-10-15
CY963A (en) 1978-12-22
YU321279A (en) 1983-04-27
GB1392674A (en) 1975-04-30
HU166213B (fr) 1975-02-28
DK142750B (da) 1981-01-12
JPS6221343B2 (fr) 1987-05-12
NL7305097A (fr) 1973-10-16
ZA732136B (en) 1974-03-27
JPS5825656B2 (ja) 1983-05-28
NL174459B (nl) 1984-01-16
AR203822A1 (es) 1975-10-31
ES413639A1 (es) 1976-01-16
CH569691A5 (fr) 1975-11-28
DE2317710C2 (de) 1983-08-04
KE2870A (en) 1978-09-01
DE2317710A1 (de) 1973-10-18
PL90695B1 (fr) 1977-01-31
YU37113B (en) 1984-08-31
BG23001A3 (bg) 1977-05-20
FR2182947A1 (fr) 1973-12-14
CS190448B2 (en) 1979-05-31
IL42016A0 (en) 1973-06-29
YU97673A (en) 1982-02-25
DD107670A5 (de) 1974-08-12
SU496719A3 (ru) 1975-12-25
SE399064B (sv) 1978-01-30
FR2182947B1 (fr) 1976-07-02
AU472734B2 (en) 1976-06-03
PL94207B1 (fr) 1977-07-30

Similar Documents

Publication Publication Date Title
AR194587A1 (es) Procedimiento para la preparacion de 2,2'metilendifenoles sustituidos
SE390819B (sv) Analogiforfarande for framstellning av piperazinyl-propyl-1,2,4-triazolinderivat
SE7710600L (sv) Forfarande for framstellning av 1,3-bensoxazoler
DK134177C (da) Fremgangsmade til fremstilling af 3-(piperazinoalkyl)-pyrazoler
AR204926A1 (es) Procedimiento para la preparacion de 2,2,6,6-tetrametil-4-oxopiperidina
AR192786A1 (es) Procedimiento para la preparacion de nuevos n-amina-terciaria-metil-4'dibenzo(b,e)oxepina-11-espiro-2'dioxolanos-1',3'
AR200007A1 (es) Procedimiento para la preparacion de nuevos oxazoles 2,4,5-trisustituidos
SE395460B (sv) Forfarande for framstellning av 2beta,16beta-dipiperidino-5alfa-androstaner
AR208393A1 (es) Procedimiento para la preparacion de 2,2,6,6-tetrametil-4-oxopiperidina
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
AR211929A1 (es) Procedimiento para la elaboracion de 7-acetil-alfa-(ter.butilaminometil)-2-benzofuranmetanol
SE431451B (sv) Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
BG20583A3 (bg) Метод за получаване на 2,6-диамино-дихидропиридини
SE420603B (sv) Forfarande for framstellning av metyl-3-(2-kinoxolinylmetylen)-karbazat-n?721, n?724-dioxid
AR199826A1 (es) Procedimiento para la preparacion de oxazoles 2,4,5-trisustituidos
AR201114A1 (es) Procedimiento para la elaboracion de nuevas aza -10,11-dihidro 5-h-dibenzo<b,e>-<1,4>-diazepinas
DK131855C (da) Fremgangsmade til fremstilling af 3,4-dihydropyridoner
AR197040A1 (es) Procedimiento de preparacion de nuevas bifenilacetamidas
AR200162A1 (es) Procedimiento para la preparacion de derivados 1,2,4-triazolicos
DK132831C (da) Analogifremgangsmade til fremstilling af 17beta-hydroxy-2,2,17-trimethyl-4-androsten-3-on
NO137725C (no) Fremgangsmaate for selektiv fremstilling av 1,2-dikloretan
DK132329C (da) Fremgangsmade til fremstilling af cardenolid-3,alfa-(2'-desoxy-glycosider)
AR193162A1 (es) Procedimiento para la preparacion de compuestos de aminoalcanamidas 2,2-disubstituidas
NO782754L (no) Analogifremgangsmaate for fremstilling av 15alfa,16alfa-methylen-4-oestren-17beta-olen
NO139298C (no) Fremgangsmaate ved fremstilling av 2,2`-anhydro-1-beta-arabino-furanosyl-5-fluor-cytosin (2,2`-anhydro-ara-fc)